Journal Watch · Nature Communications · 2026

A systematic identification of resistance determinants to antisense antibiotics suggests adaptation strategies dependent on the delivery peptide.

These findings show that CPP identity strongly determines robustness against resistance evolution, and that laboratory evolution can illuminate the mechanisms of action of asobiotics.

Mulkern AJ, Vu TH, Popella L et al.Nature Communications3 min readPharma relevance 50/100

DOI: 10.1038/s41467-026-76357-yPMID: 42586984Study type: research study

TL;DR

These findings show that CPP identity strongly determines robustness against resistance evolution, and that laboratory evolution can illuminate the mechanisms of action of asobiotics.

Key findings

  • By contrast, for (RXR)<sub>4</sub>XB-acpP we observed only a modest resistance increase, driven by mutations in the PNA binding site that could be readily bypassed by changing the PNA sequence.
  • These findings show that CPP identity strongly determines robustness against resistance evolution, and that laboratory evolution can illuminate the mechanisms of action of asobiotics.

What they did

Reduced susceptibility depended on the cell-penetrating peptide (CPP) conjugated to the PNA, with reduced uptake emerging as a common adaptation only against the (KFF)<sub>3</sub>-K CPP. Accordingly, sbmA was consistently mutated across all species treated with (KFF)<sub>3</sub>-K-conjugated PNAs. We further identified mutations related to translation, peptide transport, and the cell envelope, generating new hypotheses on the cellular response to CPP-PNA conjugates.

Full abstract (original)

Background: The rise of antimicrobial resistance (AMR) among human pathogens is a serious threat to global health, demanding novel treatment strategies. Antibiotics based on programmable antisense oligomers (asobiotics) offer an attractive solution, as their specificity can be quickly updated to target resistant bacteria. To understand the genetic architecture of resistance to asobiotics, we used laboratory evolution assays to identify mutations that decrease susceptibility to antisense peptide nucleic acids (PNAs) in four major gram-negative pathogens: Escherichia coli, Klebsiella pneumoniae, Salmonella enterica, and Pseudomonas aeruginosa.

What they did: Reduced susceptibility depended on the cell-penetrating peptide (CPP) conjugated to the PNA, with reduced uptake emerging as a common adaptation only against the (KFF)<sub>3</sub>-K CPP. Accordingly, sbmA was consistently mutated across all species treated with (KFF)<sub>3</sub>-K-conjugated PNAs. We further identified mutations related to translation, peptide transport, and the cell envelope, generating new hypotheses on the cellular response to CPP-PNA conjugates.

Results & conclusions: By contrast, for (RXR)<sub>4</sub>XB-acpP we observed only a modest resistance increase, driven by mutations in the PNA binding site that could be readily bypassed by changing the PNA sequence. These findings show that CPP identity strongly determines robustness against resistance evolution, and that laboratory evolution can illuminate the mechanisms of action of asobiotics.

Abstract © the authors / Nature Communications (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s41467-026-76357-y · PubMed 42586984.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Nature Communications for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Nature Communications study find?

These findings show that CPP identity strongly determines robustness against resistance evolution, and that laboratory evolution can illuminate the mechanisms of action of asobiotics.

What type of study is this?

It is a research study, published in Nature Communications in 2026. Reduced susceptibility depended on the cell-penetrating peptide (CPP) conjugated to the PNA, with reduced uptake emerging as a common adaptation only against the (KFF)<sub>3</sub>-K CPP.

Where can I read the original paper?

The original is at the publisher via DOI 10.1038/s41467-026-76357-y. PubMed ID: 42586984. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Mulkern AJ, Vu TH, Popella L et al.. A systematic identification of resistance determinants to antisense antibiotics suggests adaptation strategies dependent on the delivery peptide.. Nature Communications (2026). DOI: 10.1038/s41467-026-76357-y.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/a-systematic-identification-of-resistance-determinants-to-antisense-anti-76357y/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides